Indian Expert Panel Recommends Emergency Use Approval for Covaxin in 2 to 18 Age Group
An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech’s Covaxin for children in the 2 to 18 years age group with certain conditions, sources said on Tuesday.
Hyderabad-based Bharat Biotech, which completed the phase 2/3 trials of Covid vaccine Covaxin for use in children aged between 2 and 18 years, had submitted the data to the Central Drugs Standard Control Organisation (CDSCO) for its verification and subsequent approval for emergency use authorisation (EUA) for the jab in the beginning of this month.
The Subject Expert Committee (SEC) on COVID-19 examined the data and deliberated on the EUA application on Monday.
”After detailed deliberation, the committee recommended grant of market authorisation of the vaccine for the age group of 2 to 18 years for restricted use in emergency situations subject to the certain conditions,” the SEC recommendations stated.
The overall geometric mean titre (GMT) for the paediatric population is comparable with GMT of the adult population in phase -3 efficacy study, the recommendations stated.
After detailed deliberation, the committee recommended the grant of market authorisation of the vaccine for the 2 to 18 years age group for restricted use in emergency situations subject to certain conditions, they stated.
According to the conditions, the firm should continue the study as per the approved clinical trial protocol and provide updated prescribing information/package Insert (Pl), Summary of Product Characteristics (SmPC) and Factsheet, a source said.
Besides, the firm should submit safety data, including the data on AEFI and AESI, with due analysis, every 15 days for the first two months and monthly thereafter and also as per requirement of New Drugs and Clinical Trials Rules, 2019.
The popular Alai Balai program was held at Jala Vihar in the city today. The program was organized by the Haryana Governor Bandaru Dattatreya’s daughter Vijayalaxmi. Dattatreya used to hold the program every year before being elevated to the pair of the governor.
Delhi Metro constantly keeps doing something new for the convenience of its passengers. This time also DMRC has made an effort so that the passengers will get more pleasure in the journey.
A new facility with ‘substantial capacity’ for vaccine manufacturing will be opened soon in Hyderabad, with a high-level United States delegation, led by US International Development Finance Corporation (DFC) Chief Operating Officer David Marchick, to participate in a signing ceremony with regard to this later this month.
Congress leader Rahul Gandhi today lashed out at Centre over the fuel price hike and said the only growth the country is witnessing is that of inflation.
India recorded 14,146 new cases of Covid-19 during the past 24 hours pushing the country’s infection caseload to 3,40,67,719, even as the number of vaccinated people went past 97 crores, the Union Health Ministry said in an update on Sunday.
Now you can get latest stories from Indtoday on Telegram everyday. Click the link to subscribe. Click to follow Indtoday Facebook page and Twitter and on Instagram. For all the latest Hyderabad News updates